Resource Center
Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.
In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.
Resources
Publications
Group Sequential Monitoring for Trend in Proportions with Likelihood Ratio Test Statistic
22/05/2005
Kim, J., Auh, S.
Ongoing Prospective Multicenter Safety Study of Subcutaneous Cytoprotectant Amifostine for Head and Neck Carcinoma
16/10/2005
Samuels, M., Fullmer, K.R.
Ongoing, Prospective Multicenter Safety Study of Subcutaneous Amifostine for Non-Small Cell Lung Cancer (NSCLC)
13/05/2005
Nichols, R.C., Fullmer, K.R.
Recurrence of Membranoproliferative Glomerulonephritis Type II in Renal Allografts: The North American Pediatric Renal Transplant Cooperative Study Experience
07/2005
Braun, M., Stablein, D., Hamiwka, L., Bell, L., Bartosh, S., Strife, C.
Retinal Risk Factors and Progression to Geographic Atrophy in Age-Related Macular Degeneration
21/05/2005
Klein, M.L., , , Hwang, T.S., Ferris, F.L., Chew, E.Y., Gensler, G.R., Seddon, J.M., Bressler, S.B., Group, A.R.Eye Diseas
Standardization and Validation Issues of the ELISPOT Assay
2005
Janetzki, S., Cox, J.H., Oden, N., Ferrari, G.
The Effect of the PKC b Inhibitor Ruboxistaurin on Moderate Visual Loss: The PKC-DRS2 Trial Baseline Characteristics and Preliminary Results
14/10/2005
Aiello, L.P., Vignati, L., Sheetz, M.J., Zhi, X., Girach, A., Davis, M.D., Milton, R.C., Group, T.P.K.C.D.R.S.2 S.